Research
Articles
PSILOCYBIN TO BE APPROVED AS A DRUG BY THE END OF SUMMER
On Monday, Martin Makary, director of the FDA ( Food and Drug Administration) told NBC News that, with the priority voucher program, the agency could approve the first psychedelic drug by the end of this summer 2026.
VOUCHERS HAVE BEEN ISSUED TODAY....
8
min.
PSYLOCOBES MUSHROOMS TO HEAL OCD (Obsessive-Compulsive Disorder). CLINICAL TRIAL CONFIRMS
The researchers assessed symptom severity with a standard scale ranging from 0 to 40 points. They then assigned the participants to...
2
minutes
PSILOCYBE MUSHROOMS FOR SMOKING CESSATION: NEW CLINICAL TRIAL AT THE...
"A recent study from Johns Hopkins University suggests that psilocybin, the active compound in magic mushrooms, may be more effective than...
3
minutes
PSILOCYBE MUSHROOMS TO TREAT LYME DISEASE: CLINICAL TRIAL CONFIRMS...
A pilot study conducted at the prestigious Johns Hopkins Hospital Institute has found early indications that psilocybin may help alleviate...
11
minutes
AYAHUASCA STIMULATES THE «NEUROGENIC NICHES» WHICH ARE THE AREAS OF THE BRAIN THAT...
This was verified by the study of Dr. Jose Angel Morales of the Complutense University of Madrid.
The neurogenic niches are specialized regions of the adult brain...
1
minute
The environment and mentality shape the effects of ayahuasca...
In a previous review of adverse effects reported in a global survey of ayahuasca ceremony participants, José Carlos Bouso, Andión,...
3
minutes
A Brazilian university study shows that harmine can be...
"Science is beginning to seriously study yagé alkaloids. Among them, harmine shows promising effects in the laboratory: apoptosis, tumor blocking, regulation...
5
minutes